Sort By:
Relevance
Published
Display per page:
10
20
30
50
Long non-coding RNA-AK138945 regulates myocardial ischemia-reperfusion injury via the miR-1-GRP94 signaling pathway
Yanying Wang, Jian Huang, Han Sun, Jie Liu, Yingchun Shao, Manyu Gong, Xuewen Yang, Dongping Liu, Zhuo Wang, Haodong Li, Yanwei Zhang, Xiyang Zhang, Zhiyuan Du, Xiaoping Leng, Lei Jiao, Ying Zhang
2024, 4(1): 31-40. doi: 10.2478/fzm-2024-0004
Keywords: myocardial ischemia reperfusion, lncRNA, apoptosis, microRNA GRP94
  Objective  Myocardial ischemia-reperfusion injury (MIRI) is one of the leading causes of death from cardiovascular disease in humans, especially in individuals exposed to cold environments. Long non-coding RNAs (lncRNAs) regulate MIRI through multiple mechanisms.This study explored the regulatory effect of lncRNA-AK138945 on myocardial ischemia-reperfusion injury and its mechanism.  Methods  In vivo, 8- to 12-weeks-old C57BL/6 male mice underwent ligation of the left anterior descending coronary artery for 50 minutes followed by reperfusion for 48 hours. In vitro, the primary cultured neonatal mouse ventricular cardiomyocytes (NMVCs) were treated with 100 μmol/L hydrogen peroxide (H2O2). The knockdown of lncRNA-AK138945 was evaluated to detect cardiomyocyte apoptosis, and a glucose-regulated, endoplasmic reticulum stress-related protein 94 (GRP94) inhibitor was used to detect myocardial injury.  Results  We found that the expression level of lncRNA-AK138945 was reduced in MIRI mouse heart tissue and H2O2-treated cardiomyocytes. Moreover, the proportion of apoptosis in cardiomyocytes increased after lncRNA-AK138945 was silenced. The expression level of Bcl2 protein was decreased, and the expression level of Bad, Caspase 9 and Caspase 3 protein was increased. Our further study found that miR-1a-3p is a direct target of lncRNA-AK138945, after lncRNA-AK138945 was silenced in cardiomyocytes, the expression level of miR-1a-3p was increased while the expression level of its downstream protein GRP94 was decreased. Interestingly, treatment with a GRP94 inhibitor (PU-WS13) intensified H2O2-induced cardiomyocyte apoptosis. After overexpression of FOXO3, the expression levels of lncRNA-AK138945 and GRP94 were increased, while the expression levels of miR-1a-3p were decreased.  Conclusion  LncRNA-AK138945 inhibits GRP94 expression by regulating miR-1a-3p, leading to cardiomyocyte apoptosis. The transcription factor Forkhead Box Protein O3 (FOXO3) participates in cardiomyocyte apoptosis induced by endoplasmic reticulum stress through up-regulation of lncRNA-AK138945.
Therapeutic effects of Naoshuan Kangfu Capsule on post-stroke spasticity in normothermic and cold-exposed rat models
Zhiyuan Du, Kexin Wang, Zijia Liu, Yifei Wang, Bosi Sun, Yu Wang, Chenchen Yin, Tianjiao Zhao, Dan Yin, Ajiao Yu, Weijun Li, Yang Qu, Yu Liu, Lei Wang, Lei Jiao, Baofeng Yang
2026, 6(3): 150-165. doi: 10.1515/fzm-2026-0016
Keywords: post-stroke spasticity, Naoshuan Kangfu Capsule, cerebral ischemia, apoptosis, angiogenesis, inflammation
  Objective  Post-stroke spasticity (PSS), a common and debilitating complication after stroke, severely impacts patients' motor function and quality of life. Naoshuan Kangfu Capsule (NSKF) is traditionally used for the treatment of stroke, hemiplegia, aphasia, and facial paralysis caused by blood stasis obstructing collaterals; however, its therapeutic effects and underlying mechanisms in PSS remain unclear. This study investigated the protective and reparative effects of NSKF on PSS following cerebral ischemia under both normal and cold exposure conditions.  Methods  A global cerebral ischemia model was established in rats using bilateral two-vessel occlusion (2VO). PSS was evaluated using behavioral assessments, including the modified Neurological Severity Score (mNSS), balance beam test, Ashworth Scale, and sticky dot test, in 2VO rats maintained under normal and cold temperature conditions. Hematoxylin-eosin (HE) staining was used to assess cerebral histomorphological changes. RNA sequencing was conducted to identify differentially expressed genes in brain tissues. Cerebral cortex tissue neuron-specific enolase (NSE), brain vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), glutamate (Glu), and γ-aminobutyric acid (GABA) levels were measured using ELISA. qRT-PCR was used to determine the mRNA expression levels of Grm1a, Gabbr1, Interleukin-1β (IL-1β), Interleukin-6 (IL-6), Interleukin-18 (IL-18), and tumor necrosis factor-α (TNF-α). Immunofluorescence staining was performed to assess ionized calcium-binding adaptor molecule 1(IBA-1) and cluster of differentiation 31 (CD31) expression. Apoptosis was evaluated using TUNEL staining and Caspase-3 assay.  Results  NSKF significantly alleviated PSS in 2VO rats at 5 and 10 weeks after cerebral ischemia, as evidenced by multiple behavioral assessments, with effects comparable to those of the positive control drug Baclofen. NSKF suppressed NSE and IBA-1 activation, indicating attenuation of neuronal injury and neuroinflammation. RNA sequencing revealed that NSKF regulated pathways associated with apoptosis, angiogenesis, and inflammatory responses. Subsequent validation confirmed that NSKF inhibited neuronal apoptosis, as evidenced by reduced cell death and caspase-3 activity, while promoting angiogenesis through increased CD31 and VEGF expression. In addition, NSKF modulated neurotransmitter homeostasis by decreasing cortical Glu/GABA levels, and upregulating the expression of metabotropic glutamate receptor 1a (Grm1a) and GABA B receptor 1 (Gabbr1). However, NSKF did not significantly affect neuronal proliferation. Furthermore, NSKF suppressed neuroinflammation by reducing IBA-1 activation and pro-inflammatory cytokine expression (IL-1β, IL-6, IL-18, and TNF-α), potentially through inhibition of the NF-κB signaling pathway. Notably, NSKF maintained its therapeutic efficacy against PSS in 2VO rats exposed to chronic cold conditions. Long-term administration of NSKF (50, 400, 800, and 1600 mg/kg for 10 weeks) produced no observable toxic effects.  Conclusions  NSKF improves neurological deficits and alleviates post-stroke spasticity after cerebral ischemic injury by reducing neuronal apoptosis, enhancing angiogenesis, suppressing neuroinflammation, and restoring Glu/GABA neurotransmitter balance. Its sustained efficacy under cold exposure conditions suggests potential advantages for patients living in cold environments. These findings provide experimental evidence for the therapeutic potential of NSKF as a candidate intervention for post-stroke spasticity.
Growth differentiation factor 11 promotes macrophage polarization towards M2 to attenuate myocardial infarction via inhibiting Notch1 signaling pathway
Manyu Gong, Xuewen Yang, Yaqi Wang, Yanying Wang, Dongping Liu, Haodong Li, Yunmeng Qu, Xiyang Zhang, Yanwei Zhang, Han Sun, Lei Jiao, Ying Zhang
2023, 3(1): 53-64. doi: 10.2478/fzm-2023-0008
Keywords: myocardial infarction, growth differentiation factor 11, M1 macrophage, M2 macrophage, Notch1
  Background  Myocardial infarctions (MI) is a major threat to human health especially in people exposed to cold environment. The polarization of macrophages towards different functional phenotypes (M1 macrophages and M2 macrophages) is closely related to MI repairment. The growth differentiation factor 11 (GDF11) has been reported to play a momentous role in inflammatory associated diseases. In this study, we examined the regulatory role of GDF11 in macrophage polarization and elucidated the underlying mechanisms in MI.  Methods  In vivo, the mice model of MI was induced by permanent ligation of the left anterior descending coronary artery (LAD), and mice were randomly divided into the sham group, MI group, and MI+GDF11 group. The protective effect of GDF11 on myocardial infarction and its effect on macrophage polarization were verified by echocardiography, triphenyl tetrazolium chloride staining and immunofluorescence staining of heart tissue. In vitro, based on the RAW264.7 cell line, the effect of GDF11 in promoting macrophage polarization toward the M2 type by inhibiting the Notch1 Signaling pathway was validated by qRT-PCR, Western blot, and flow cytometry.  Results  We found that GDF11 was significantly downregulated in the cardiac tissue of MI mice. And GDF11 supplementation can improve the cardiac function. Moreover, GDF11 could reduce the proportion of M1 macrophages and increase the accumulation of M2 macrophages in the heart tissue of MI mice. Furthermore, the cardioprotective effect of GDF11 on MI mice was weakened after macrophage clearance. At the cellular level, application of GDF11 could inhibit the expression of M1 macrophage (classically activated macrophage) markers iNOS, interleukin (IL)-1β, and IL-6 in a dose-dependent manner. In contrast, GDF11 significantly increased the level of M2 macrophage markers including IL-10, CD206, arginase 1 (Arg1), and vascular endothelial growth factor (VEGF). Interestingly, GDF11 could promote M1 macrophages polarizing to M2 macrophages. At the molecular level, GDF11 significantly down-regulated the Notch1 signaling pathway, the activation of which has been demonstrated to promote M1 polarization in macrophages.  Conclusions  GDF11 promoted macrophage polarization towards M2 to attenuate myocardial infarction via inhibiting Notch1 signaling pathway.